Volume 179, Issue 4 (April, 2022)
Editor’s Note
1. Integrating Clinical and Basic Research: Opioid Use Disorder, Psychotic Illnesses, and Prefrontal Microcircuits Relevant to Schizophrenia
- Ned H. Kalin, M.D.
- Pages:255–258
Editorials
2. Reducing Duration of Untreated Psychosis: The Neglected Dimension of Early Intervention Services
- Ashok Malla, M.B.B.S., F.R.C.P.C., M.R.C.Psych.
- Pages:259–261
3. Medication Treatment for Opioid Use Disorder Reduces Suicide Risk
- Larissa J. Mooney, M.D.
- Pages:262–263
4. Opioid Prescribing and the Very Human Toll of Drug Harms
- Maree Teesson, Ph.D.
- Pages:264–266
Reviews and Overviews
5. Transforming Discoveries About Cortical Microcircuits and Gamma Oscillations Into New Treatments for Cognitive Deficits in Schizophrenia
- Vikaas S. Sohal, M.D., Ph.D.
- Pages:267–276
Articles
6. Synaptic Variability and Cortical Gamma Oscillation Power in Schizophrenia
- Daniel W. Chung, M.D., Ph.D., Matthew A. Geramita, M.D., Ph.D., David A. Lewis, M.D.
- Pages:277–287
7. 20-Year Prospective, Sequential Follow-Up Study of Heterogeneity in Associations of Duration of Untreated Psychosis With Symptoms, Functioning, and Quality of Life Following First-Episode Psychosis
- Donal O’Keeffe, Ph.D., Anthony Kinsella, M.Sc., John L. Waddington, Ph.D., D.Sc., Mary Clarke, M.D.
- Pages:288–297
8. Association of Medication Treatment for Opioid Use Disorder With Suicide Mortality
- Bradley V. Watts, M.D., M.P.H., Daniel J. Gottlieb, M.S., Natalie B. Riblet, M.D., M.P.H., Jiang Gui, Ph.D., Brian Shiner, M.D., M.P.H.
- Pages:298–304
9. Effects of County-Level Opioid Dispensing Rates on Individual-Level Patterns of Prescription Opioid and Heroin Consumption: Evidence From National U.S. Data
- Mike Vuolo, Ph.D., Brian C. Kelly, Ph.D.
- Pages:305–311
Other Items Of Interest
10. Disclosure of Editors’ Financial Relationships
- Page:312
11. Correction to Mattes
- Page:312